In Treatment of High uric acid due to chemotherapy Certain types of cancer, like kidney or bladder cancer, may cause high levels of uric acid due to ongoing cancer chemotherapy. This can worsen patient health conditions and also lead to more serious health issues. Rascas 1.5mg Injection helps reduce these high levels of uric acid and prevents further complications. This will ensure speedy recovery and improve your quality of life. Follow your doctor’s instructions and let your doctor know if you have any concerns.
It is not known whether it is safe to consume alcohol with Rascas 1.5mg Injection. Please consult your doctor.
Rascas 1.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Rascas 1.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Rascas 1.5mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Rascas 1.5mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Rascas 1.5mg Injection may not be needed in these patients. Please consult your doctor.
Rascas 1.5mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Rascas 1.5mg Injection may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Natco Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Celon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aureate Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)